IVI, INOVIO, and KNIH partner with CEPI in a Phase I/II trial of INOVIO's COVID-19 vaccine - EurekAlert

IVI, INOVIO, and KNIH partner with CEPI in a Phase I/II trial of INOVIO's COVID-19 vaccine  EurekAlert

Comments

Popular posts from this blog